O

Oculis Holding AG
NASDAQ:OCS

Watchlist Manager
Oculis Holding AG
NASDAQ:OCS
Watchlist
Price: 19.43 USD -2.07%
Market Cap: 1.1B USD

Operating Margin
Oculis Holding AG

0%
Current
0%
Average
6.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-78.3m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Oculis Holding AG
Glance View

Market Cap
1.1B USD
Industry
Pharmaceuticals

Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improve eye care. The company is headquartered in Zug, Zug and currently employs 28 full-time employees. The firm is focused on the development of eye disease treatment for ophthalmology. The company includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The firm have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

OCS Intrinsic Value
17.3 USD
Overvaluation 11%
Intrinsic Value
Price
O
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-78.3m
/
Revenue
0
What is the Operating Margin of Oculis Holding AG?

Based on Oculis Holding AG's most recent financial statements, the company has Operating Margin of 0%.

Back to Top